316 results
8-K
EX-4.1
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid … in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
8-K
EX-10.1
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
awards to employees, officers, directors or consultants of the Company pursuant to any equity or option plan duly adopted for such purpose, by a majority … of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established
8-K
EX-4.2
SEEL
Seelos Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
4:01pm
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company … by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably
424B5
SEEL
Seelos Therapeutics Inc
20 May 24
Prospectus supplement for primary offering
4:16pm
in the registrational Phase II/III study for the treatment of SCA. In March 2023, we announced that in order to focus the majority of our resources on the Phase II study … from regulatory agencies.
In March 2023, we announced that in order to focus the majority of our resources on the Phase II study of SLS-002 (intranasal
8-K
EX-99.1
n3ytv40ndd c15ny
19 Mar 24
Other Events
4:05pm
424B3
6ubhrplv niv2z5
15 Mar 24
Prospectus supplement
4:15pm
8-K
EX-4.1
c3f7thx9xf 5jkbwp
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
fmun7
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
424B5
og95bptp
30 Jan 24
Prospectus supplement for primary offering
6:05am
8-K
EX-4.1
ov6x2q
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm